论文部分内容阅读
目的:探讨三联疗法在对消化性溃疡患者实施治疗过程中的临床效果。方法:选取2011年12月至2013年12月在我院接受消化性溃疡治疗的患者124例为研究对象,随机分为观察组和对照组,每组62例患者。观察组患者给予奥美拉唑、克拉霉素和阿莫西林三联治疗,对照组患者给予雷宁替丁、克拉霉素和阿莫西林三联治疗。结果:观察组患者临床治疗有效率以及幽门螺杆菌清除率明显优于对照组,具有统计学意义(p<0.05)。结论:在消化性溃疡患者实施治疗的过程中,奥美拉唑、克拉霉素和阿莫西林三联治疗的运用可以提高临床治疗的有效率和幽门螺杆菌清除率,安全性较高,具有显著的效果,值得临床推广。
Objective: To investigate the clinical effect of triple therapy in the treatment of patients with peptic ulcer. Methods: A total of 124 patients with peptic ulcer in our hospital from December 2011 to December 2013 were selected as study subjects and randomly divided into observation group and control group, with 62 patients in each group. Patients in the observation group were treated with omeprazole, clarithromycin and amoxicillin triple therapy, while patients in the control group were treated with triple therapy of salbutamol, clarithromycin and amoxicillin. Results: The clinical efficacy rate and Helicobacter pylori eradication rate in the observation group were significantly better than those in the control group (p <0.05). Conclusion: In the treatment of patients with peptic ulcer, omeprazole, clarithromycin and amoxicillin triple therapy can improve the efficiency of clinical treatment and H. pylori clearance, high safety, with significant The effect is worth clinical promotion.